MS 3

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 534788

CAS#: 58265-74-0

Description: MS 3 is a bioactive chemical.


Chemical Structure

img
MS 3
CAS# 58265-74-0

Theoretical Analysis

MedKoo Cat#: 534788
Name: MS 3
CAS#: 58265-74-0
Chemical Formula: C21H24O7
Exact Mass: 388.1522
Molecular Weight: 388.416
Elemental Analysis: C, 64.94; H, 6.23; O, 28.83

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: MS 3; MS-3; MS3

IUPAC/Chemical Name: beta-Resorcylic acid, 6-methyl-, 3,4-bis(hydroxymethyl)-5-hydroxy-6-(3-methyl-2-butenyl)phenyl ester

InChi Key: WTZUCTQSBSDSRG-UHFFFAOYSA-N

InChi Code: InChI=1S/C21H24O7/c1-11(2)4-5-15-18(7-13(9-22)16(10-23)20(15)26)28-21(27)19-12(3)6-14(24)8-17(19)25/h4,6-8,22-26H,5,9-10H2,1-3H3

SMILES Code: OC1=CC(O)=CC(C)=C1C(OC2=C(C/C=C(C)\C)C(O)=C(CO)C(CO)=C2)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 388.416 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Granier C, Gey A, Dariane C, Mejean A, Timsit MO, Blanc C, Verkarre V, Radulescu C, Fabre E, Vano Y, Oudard S, Badoual C, Tartour É. Tim-3 - Biomarqueur et cible thérapeutique en cancérologie [Tim-3: a novel biomarker and therapeutic target in oncology]. Med Sci (Paris). 2018 Mar;34(3):231-237. French. doi: 10.1051/medsci/20183403011. Epub 2018 Mar 16. PMID: 29547109.

2: Hamaï A, Mehrpour M. Homéostasie du fer et autophagie [Autophagy and iron homeostasis]. Med Sci (Paris). 2017 Mar;33(3):260-267. French. doi: 10.1051/medsci/20173303012. Epub 2017 Apr 3. PMID: 28367812.

3: Bonnefoy N, Olive D, Vanhove B. Les futures générations d’anticorps modulateurs des points de contrôle de la réponse immunitaire [Next generation of anti-immune checkpoints antibodies]. Med Sci (Paris). 2019 Dec;35(12):966-974. French. doi: 10.1051/medsci/2019193. Epub 2020 Jan 6. PMID: 31903901.

4: Saintamand A, Ghazzaui N, Issaoui H, Denizot Y. 3’RR - Docteur Jekyll et Mister Hyde de la lymphopoïèse/lymphomagenèse B [The IgH 3'RR: Doctor Jekyll and Mister Hyde of B-cell maturation and lymphomagenesis]. Med Sci (Paris). 2017 Nov;33(11):963-970. French. doi: 10.1051/medsci/20173311013. Epub 2017 Dec 4. PMID: 29200394.

5: Jordan B. Bébés CRISPR - Anatomie d’une transgression [CRISPR babies: technology and transgression]. Med Sci (Paris). 2019 Mar;35(3):266-270. French. doi: 10.1051/medsci/2019034. Epub 2019 Apr 1. PMID: 30931913.

6: Bossu JL, Roux S. Les modèles animaux d’étude de l’autisme - Le modèle « valproate » [The valproate model of autism]. Med Sci (Paris). 2019 Mar;35(3):236-243. French. doi: 10.1051/medsci/2019036. Epub 2019 Apr 1. PMID: 30931908.

7: Béganton B, Coyaud E, Mangé A, Solassol J. Approches nouvelles pour l’étude des interactions protéine-protéine [New approaches for protein-protein interaction study]. Med Sci (Paris). 2019 Mar;35(3):223-231. French. doi: 10.1051/medsci/2019035. Epub 2019 Apr 1. PMID: 30931906.

8: Galais M, Pradel B, Vergne I, Robert-Hebmann V, Espert L, Biard-Piechaczyk M. La phagocytose associée à LC3 (LAP) - Phagocytose ou autophagie ? [LAP (LC3-associated phagocytosis): phagocytosis or autophagy?]. Med Sci (Paris). 2019 Aug-Sep;35(8-9):635-642. French. doi: 10.1051/medsci/2019129. Epub 2019 Sep 18. PMID: 31532375.

9: Bonne G, Pouget J. L’errance diagnostique au cœur des préoccupations du 3e Plan National Maladies Rares [Diagnostic odyssey at the heart of the 3rd National Initiative for Rare Disorders]. Med Sci (Paris). 2018 Nov;34 Hors série n°2:5. French. doi: 10.1051/medsci/201834s201. Epub 2018 Nov 12. PMID: 30418136.

10: Henry JP. Génétique et origine d’Homo sapiens [Genetics and origin of Homo sapiens]. Med Sci (Paris). 2019 Jan;35(1):39-45. French. doi: 10.1051/medsci/2018311. Epub 2019 Jan 23. PMID: 30672457.

11: Monsan P. Session 3. Caractériser les dynamiques scientifiques de la biologie de synthèse. Introduction [Session 3. Characterizing the scientific dynamics of synthetic biology. Introduction]. Med Sci (Paris). 2013 May;29 Spec No 2:41-2. French. doi: 10.1051/medsci/201329s211. Epub 2013 Jun 7. PMID: 23759495.

12: Gaudillière JP. Session 3. Facons de connaitre. Un nouveau paradigme pour la recherche pour la recherche en biologie [Session 3. Ways of knowing- a new paradigm for biology research]. Med Sci (Paris). 2012 Jun-Jul;28 Spec No 2:33. French. doi: 10.1051/medsci/201228s209. Epub 2012 Jun 29. PMID: 22759894.

13: Goy E, Abbadie C. Sénescence et cancer - Double jeu [Senescence and cancer: double-dealing]. Med Sci (Paris). 2018 Mar;34(3):223-230. French. doi: 10.1051/medsci/20183403010. Epub 2018 Mar 16. PMID: 29547108.

14: Falissard B. La maladie mentale, une maladie comme les autres ? [Mental illness, just another disease?]. Med Sci (Paris). 2018 Mar;34(3):195-196. French. doi: 10.1051/medsci/20183403001. Epub 2018 Mar 16. PMID: 29547099.

15: Villarejo-Zori B, Boya P. Autophagie et vision [Autophagy and vision]. Med Sci (Paris). 2017 Mar;33(3):297-304. French. doi: 10.1051/medsci/20173303017. Epub 2017 Apr 3. PMID: 28367817.

16: Benani A, Gaudet C, Varennes O, Vellas D. L’actualité scientifique vue par les étudiants de l’AMPS - Some scientific highlights: a selection by MD/Pharmacy-PhD students. Med Sci (Paris). 2018 Apr;34(4):313. French. doi: 10.1051/medsci/20183404011. Epub 2018 Apr 16. PMID: 29658473.

17: Pallet N. Autophagie rénale [Autophagy in the kidney]. Med Sci (Paris). 2017 Mar;33(3):275-282. French. doi: 10.1051/medsci/20173303014. Epub 2017 Apr 3. PMID: 28367814.

18: Agus A, Sokol H. Tryptophane et dérégulations métaboliques, un nouvel enjeu pour la santé [Tryptophan and metabolic syndrome, a new challenge for health]. Med Sci (Paris). 2019 Mar;35(3):213-215. French. doi: 10.1051/medsci/2019040. Epub 2019 Apr 1. PMID: 30931904.

19: Crinier A, Viant C, Girard-Madoux M, Vivier É. Les cellules lymphoïdes innées [Innate lymphoid cells]. Med Sci (Paris). 2017 May;33(5):534-542. French. doi: 10.1051/medsci/20173305018. Epub 2017 Jun 14. PMID: 28612730.

20: Bourre JM. Acides gras oméga-3 et troubles psychiatriques [Omega-3 fatty acids in psychiatry]. Med Sci (Paris). 2005 Feb;21(2):216-21. French. doi: 10.1051/medsci/2005212216. PMID: 15691497.